nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—ALB—hematologic cancer	0.129	1	CbGaD
Fosphenytoin—CYP2B6—Thiotepa—hematologic cancer	0.0346	0.0612	CbGbCtD
Fosphenytoin—CYP2C9—Bexarotene—hematologic cancer	0.022	0.039	CbGbCtD
Fosphenytoin—CYP2B6—Ifosfamide—hematologic cancer	0.0196	0.0347	CbGbCtD
Fosphenytoin—CYP2C8—Bortezomib—hematologic cancer	0.0194	0.0343	CbGbCtD
Fosphenytoin—ALB—Imatinib—hematologic cancer	0.0184	0.0325	CbGbCtD
Fosphenytoin—CYP2C9—Idarubicin—hematologic cancer	0.0183	0.0323	CbGbCtD
Fosphenytoin—CYP2B6—Nilotinib—hematologic cancer	0.017	0.0301	CbGbCtD
Fosphenytoin—CYP2C19—Bortezomib—hematologic cancer	0.0162	0.0287	CbGbCtD
Fosphenytoin—CYP2C8—Ifosfamide—hematologic cancer	0.0148	0.0263	CbGbCtD
Fosphenytoin—CYP2C19—Thalidomide—hematologic cancer	0.0141	0.025	CbGbCtD
Fosphenytoin—CYP2C9—Bortezomib—hematologic cancer	0.0135	0.0239	CbGbCtD
Fosphenytoin—CYP2C19—Teniposide—hematologic cancer	0.0135	0.0239	CbGbCtD
Fosphenytoin—CYP2C8—Nilotinib—hematologic cancer	0.0129	0.0228	CbGbCtD
Fosphenytoin—CYP3A4—Bexarotene—hematologic cancer	0.0128	0.0227	CbGbCtD
Fosphenytoin—CYP2C19—Ifosfamide—hematologic cancer	0.0125	0.022	CbGbCtD
Fosphenytoin—ALB—Prednisone—hematologic cancer	0.0121	0.0214	CbGbCtD
Fosphenytoin—CYP3A4—Lomustine—hematologic cancer	0.0119	0.0211	CbGbCtD
Fosphenytoin—CYP3A4—Busulfan—hematologic cancer	0.0119	0.0211	CbGbCtD
Fosphenytoin—CYP2C19—Imatinib—hematologic cancer	0.0119	0.0211	CbGbCtD
Fosphenytoin—CYP2C9—Thalidomide—hematologic cancer	0.0118	0.0208	CbGbCtD
Fosphenytoin—CYP2B6—Irinotecan—hematologic cancer	0.0117	0.0207	CbGbCtD
Fosphenytoin—ALB—Irinotecan—hematologic cancer	0.0115	0.0203	CbGbCtD
Fosphenytoin—CYP2C9—Teniposide—hematologic cancer	0.0112	0.0199	CbGbCtD
Fosphenytoin—CYP3A4—Thiotepa—hematologic cancer	0.0106	0.0188	CbGbCtD
Fosphenytoin—CYP2C9—Ifosfamide—hematologic cancer	0.0104	0.0183	CbGbCtD
Fosphenytoin—CYP2C9—Imatinib—hematologic cancer	0.00989	0.0175	CbGbCtD
Fosphenytoin—CYP2B6—Cisplatin—hematologic cancer	0.00953	0.0169	CbGbCtD
Fosphenytoin—CYP2C9—Nilotinib—hematologic cancer	0.00899	0.0159	CbGbCtD
Fosphenytoin—CYP3A4—Methoxsalen—hematologic cancer	0.00825	0.0146	CbGbCtD
Fosphenytoin—CYP3A4—Bortezomib—hematologic cancer	0.00785	0.0139	CbGbCtD
Fosphenytoin—CYP2C19—Prednisone—hematologic cancer	0.00784	0.0139	CbGbCtD
Fosphenytoin—CYP2B6—Dexamethasone—hematologic cancer	0.0077	0.0136	CbGbCtD
Fosphenytoin—CYP3A4—Daunorubicin—hematologic cancer	0.00751	0.0133	CbGbCtD
Fosphenytoin—CYP2C8—Etoposide—hematologic cancer	0.0071	0.0126	CbGbCtD
Fosphenytoin—CYP3A4—Cytarabine—hematologic cancer	0.00662	0.0117	CbGbCtD
Fosphenytoin—CYP3A4—Teniposide—hematologic cancer	0.00652	0.0115	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—hematologic cancer	0.00639	0.0113	CbGbCtD
Fosphenytoin—ALB—Methotrexate—hematologic cancer	0.00607	0.0107	CbGbCtD
Fosphenytoin—CYP3A4—Ifosfamide—hematologic cancer	0.00602	0.0107	CbGbCtD
Fosphenytoin—CYP2C8—Dexamethasone—hematologic cancer	0.00583	0.0103	CbGbCtD
Fosphenytoin—CYP3A4—Imatinib—hematologic cancer	0.00575	0.0102	CbGbCtD
Fosphenytoin—CYP3A4—Ruxolitinib—hematologic cancer	0.00542	0.00959	CbGbCtD
Fosphenytoin—CYP3A4—Nilotinib—hematologic cancer	0.00523	0.00925	CbGbCtD
Fosphenytoin—CYP3A4—Vinorelbine—hematologic cancer	0.00518	0.00917	CbGbCtD
Fosphenytoin—CYP2C9—Cisplatin—hematologic cancer	0.00504	0.00891	CbGbCtD
Fosphenytoin—CYP2C19—Dexamethasone—hematologic cancer	0.00489	0.00866	CbGbCtD
Fosphenytoin—CYP3A4—Triamcinolone—hematologic cancer	0.00474	0.00839	CbGbCtD
Fosphenytoin—CYP3A4—Dasatinib—hematologic cancer	0.00462	0.00818	CbGbCtD
Fosphenytoin—CYP3A4—Mitoxantrone—hematologic cancer	0.00456	0.00808	CbGbCtD
Fosphenytoin—CYP2C9—Dexamethasone—hematologic cancer	0.00407	0.0072	CbGbCtD
Fosphenytoin—CYP3A4—Betamethasone—hematologic cancer	0.00407	0.0072	CbGbCtD
Fosphenytoin—CYP3A4—Prednisolone—hematologic cancer	0.00401	0.0071	CbGbCtD
Fosphenytoin—CYP3A4—Prednisone—hematologic cancer	0.00379	0.00671	CbGbCtD
Fosphenytoin—CYP3A4—Irinotecan—hematologic cancer	0.00359	0.00636	CbGbCtD
Fosphenytoin—CYP3A4—Vinblastine—hematologic cancer	0.00319	0.00565	CbGbCtD
Fosphenytoin—CYP3A4—Vincristine—hematologic cancer	0.00314	0.00556	CbGbCtD
Fosphenytoin—CYP3A4—Etoposide—hematologic cancer	0.00288	0.00509	CbGbCtD
Fosphenytoin—CYP3A4—Dexamethasone—hematologic cancer	0.00237	0.00419	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—hematologic cancer	0.00196	0.00347	CbGbCtD
Fosphenytoin—Headache—Mitoxantrone—hematologic cancer	2.47e-05	9.16e-05	CcSEcCtD
Fosphenytoin—Headache—Irinotecan—hematologic cancer	2.47e-05	9.16e-05	CcSEcCtD
Fosphenytoin—Nausea—Ifosfamide—hematologic cancer	2.47e-05	9.14e-05	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.46e-05	9.11e-05	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.46e-05	9.11e-05	CcSEcCtD
Fosphenytoin—Myalgia—Prednisone—hematologic cancer	2.46e-05	9.09e-05	CcSEcCtD
Fosphenytoin—Arthralgia—Prednisone—hematologic cancer	2.46e-05	9.09e-05	CcSEcCtD
Fosphenytoin—Feeling abnormal—Triamcinolone—hematologic cancer	2.46e-05	9.09e-05	CcSEcCtD
Fosphenytoin—Diarrhoea—Cisplatin—hematologic cancer	2.45e-05	9.08e-05	CcSEcCtD
Fosphenytoin—Vomiting—Gemcitabine—hematologic cancer	2.45e-05	9.05e-05	CcSEcCtD
Fosphenytoin—Insomnia—Dexamethasone—hematologic cancer	2.45e-05	9.05e-05	CcSEcCtD
Fosphenytoin—Insomnia—Betamethasone—hematologic cancer	2.45e-05	9.05e-05	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—hematologic cancer	2.44e-05	9.03e-05	CcSEcCtD
Fosphenytoin—Paraesthesia—Dexamethasone—hematologic cancer	2.43e-05	8.98e-05	CcSEcCtD
Fosphenytoin—Paraesthesia—Betamethasone—hematologic cancer	2.43e-05	8.98e-05	CcSEcCtD
Fosphenytoin—Discomfort—Prednisone—hematologic cancer	2.43e-05	8.98e-05	CcSEcCtD
Fosphenytoin—Rash—Gemcitabine—hematologic cancer	2.43e-05	8.98e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Gemcitabine—hematologic cancer	2.42e-05	8.97e-05	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—hematologic cancer	2.42e-05	8.94e-05	CcSEcCtD
Fosphenytoin—Headache—Gemcitabine—hematologic cancer	2.41e-05	8.92e-05	CcSEcCtD
Fosphenytoin—Nausea—Vincristine—hematologic cancer	2.41e-05	8.91e-05	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—hematologic cancer	2.4e-05	8.9e-05	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—hematologic cancer	2.39e-05	8.83e-05	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—hematologic cancer	2.38e-05	8.81e-05	CcSEcCtD
Fosphenytoin—Dyspepsia—Dexamethasone—hematologic cancer	2.38e-05	8.81e-05	CcSEcCtD
Fosphenytoin—Dyspepsia—Betamethasone—hematologic cancer	2.38e-05	8.81e-05	CcSEcCtD
Fosphenytoin—Urticaria—Triamcinolone—hematologic cancer	2.37e-05	8.76e-05	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—hematologic cancer	2.36e-05	8.74e-05	CcSEcCtD
Fosphenytoin—Asthenia—Etoposide—hematologic cancer	2.36e-05	8.72e-05	CcSEcCtD
Fosphenytoin—Body temperature increased—Triamcinolone—hematologic cancer	2.36e-05	8.72e-05	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Prednisone—hematologic cancer	2.35e-05	8.71e-05	CcSEcCtD
Fosphenytoin—Decreased appetite—Betamethasone—hematologic cancer	2.35e-05	8.7e-05	CcSEcCtD
Fosphenytoin—Decreased appetite—Dexamethasone—hematologic cancer	2.35e-05	8.7e-05	CcSEcCtD
Fosphenytoin—Nausea—Mitoxantrone—hematologic cancer	2.35e-05	8.68e-05	CcSEcCtD
Fosphenytoin—Nausea—Irinotecan—hematologic cancer	2.35e-05	8.68e-05	CcSEcCtD
Fosphenytoin—Infection—Prednisone—hematologic cancer	2.34e-05	8.66e-05	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—hematologic cancer	2.33e-05	8.63e-05	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—hematologic cancer	2.33e-05	8.61e-05	CcSEcCtD
Fosphenytoin—Pruritus—Etoposide—hematologic cancer	2.32e-05	8.6e-05	CcSEcCtD
Fosphenytoin—Shock—Prednisone—hematologic cancer	2.32e-05	8.57e-05	CcSEcCtD
Fosphenytoin—Tachycardia—Prednisone—hematologic cancer	2.3e-05	8.5e-05	CcSEcCtD
Fosphenytoin—Nausea—Gemcitabine—hematologic cancer	2.29e-05	8.46e-05	CcSEcCtD
Fosphenytoin—Vomiting—Cisplatin—hematologic cancer	2.28e-05	8.44e-05	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Prednisone—hematologic cancer	2.28e-05	8.42e-05	CcSEcCtD
Fosphenytoin—Rash—Cisplatin—hematologic cancer	2.26e-05	8.37e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Cisplatin—hematologic cancer	2.26e-05	8.36e-05	CcSEcCtD
Fosphenytoin—Diarrhoea—Etoposide—hematologic cancer	2.25e-05	8.32e-05	CcSEcCtD
Fosphenytoin—Anorexia—Prednisone—hematologic cancer	2.24e-05	8.31e-05	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—hematologic cancer	2.24e-05	8.28e-05	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—hematologic cancer	2.24e-05	8.27e-05	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—hematologic cancer	2.23e-05	8.25e-05	CcSEcCtD
Fosphenytoin—Feeling abnormal—Dexamethasone—hematologic cancer	2.23e-05	8.24e-05	CcSEcCtD
Fosphenytoin—Feeling abnormal—Betamethasone—hematologic cancer	2.23e-05	8.24e-05	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—hematologic cancer	2.22e-05	8.23e-05	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—hematologic cancer	2.21e-05	8.19e-05	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—hematologic cancer	2.21e-05	8.18e-05	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—hematologic cancer	2.19e-05	8.11e-05	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—hematologic cancer	2.18e-05	8.08e-05	CcSEcCtD
Fosphenytoin—Malaise—Methotrexate—hematologic cancer	2.17e-05	8.05e-05	CcSEcCtD
Fosphenytoin—Dizziness—Etoposide—hematologic cancer	2.17e-05	8.04e-05	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—hematologic cancer	2.17e-05	8.03e-05	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—hematologic cancer	2.17e-05	8.02e-05	CcSEcCtD
Fosphenytoin—Leukopenia—Methotrexate—hematologic cancer	2.16e-05	7.99e-05	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—hematologic cancer	2.15e-05	7.96e-05	CcSEcCtD
Fosphenytoin—Urticaria—Dexamethasone—hematologic cancer	2.15e-05	7.95e-05	CcSEcCtD
Fosphenytoin—Urticaria—Betamethasone—hematologic cancer	2.15e-05	7.95e-05	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.15e-05	7.94e-05	CcSEcCtD
Fosphenytoin—Dizziness—Prednisolone—hematologic cancer	2.14e-05	7.93e-05	CcSEcCtD
Fosphenytoin—Asthenia—Triamcinolone—hematologic cancer	2.14e-05	7.91e-05	CcSEcCtD
Fosphenytoin—Body temperature increased—Dexamethasone—hematologic cancer	2.14e-05	7.91e-05	CcSEcCtD
Fosphenytoin—Body temperature increased—Betamethasone—hematologic cancer	2.14e-05	7.91e-05	CcSEcCtD
Fosphenytoin—Nausea—Cisplatin—hematologic cancer	2.13e-05	7.88e-05	CcSEcCtD
Fosphenytoin—Insomnia—Prednisone—hematologic cancer	2.13e-05	7.88e-05	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisone—hematologic cancer	2.11e-05	7.82e-05	CcSEcCtD
Fosphenytoin—Pruritus—Triamcinolone—hematologic cancer	2.11e-05	7.8e-05	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—hematologic cancer	2.1e-05	7.79e-05	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—hematologic cancer	2.09e-05	7.75e-05	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—hematologic cancer	2.09e-05	7.73e-05	CcSEcCtD
Fosphenytoin—Vomiting—Etoposide—hematologic cancer	2.09e-05	7.73e-05	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—hematologic cancer	2.09e-05	7.72e-05	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—hematologic cancer	2.07e-05	7.67e-05	CcSEcCtD
Fosphenytoin—Dyspepsia—Prednisone—hematologic cancer	2.07e-05	7.67e-05	CcSEcCtD
Fosphenytoin—Rash—Etoposide—hematologic cancer	2.07e-05	7.66e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Etoposide—hematologic cancer	2.07e-05	7.66e-05	CcSEcCtD
Fosphenytoin—Headache—Etoposide—hematologic cancer	2.06e-05	7.62e-05	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—hematologic cancer	2.06e-05	7.61e-05	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—hematologic cancer	2.05e-05	7.6e-05	CcSEcCtD
Fosphenytoin—Arthralgia—Methotrexate—hematologic cancer	2.05e-05	7.6e-05	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—hematologic cancer	2.05e-05	7.58e-05	CcSEcCtD
Fosphenytoin—Decreased appetite—Prednisone—hematologic cancer	2.05e-05	7.57e-05	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—hematologic cancer	2.04e-05	7.57e-05	CcSEcCtD
Fosphenytoin—Rash—Prednisolone—hematologic cancer	2.04e-05	7.56e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisolone—hematologic cancer	2.04e-05	7.55e-05	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—hematologic cancer	2.04e-05	7.53e-05	CcSEcCtD
Fosphenytoin—Headache—Prednisolone—hematologic cancer	2.03e-05	7.51e-05	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—hematologic cancer	2.03e-05	7.5e-05	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—hematologic cancer	2.03e-05	7.5e-05	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—hematologic cancer	2.03e-05	7.5e-05	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—hematologic cancer	2.02e-05	7.49e-05	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—hematologic cancer	2.02e-05	7.47e-05	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—hematologic cancer	2.02e-05	7.47e-05	CcSEcCtD
Fosphenytoin—Constipation—Prednisone—hematologic cancer	2.01e-05	7.45e-05	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—hematologic cancer	2.01e-05	7.43e-05	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—hematologic cancer	1.99e-05	7.38e-05	CcSEcCtD
Fosphenytoin—Confusional state—Methotrexate—hematologic cancer	1.98e-05	7.34e-05	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—hematologic cancer	1.98e-05	7.34e-05	CcSEcCtD
Fosphenytoin—Dizziness—Triamcinolone—hematologic cancer	1.97e-05	7.29e-05	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—hematologic cancer	1.97e-05	7.29e-05	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—hematologic cancer	1.97e-05	7.28e-05	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—hematologic cancer	1.96e-05	7.23e-05	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—hematologic cancer	1.96e-05	7.23e-05	CcSEcCtD
Fosphenytoin—Nausea—Etoposide—hematologic cancer	1.95e-05	7.22e-05	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—hematologic cancer	1.95e-05	7.21e-05	CcSEcCtD
Fosphenytoin—Feeling abnormal—Prednisone—hematologic cancer	1.94e-05	7.18e-05	CcSEcCtD
Fosphenytoin—Asthenia—Dexamethasone—hematologic cancer	1.94e-05	7.18e-05	CcSEcCtD
Fosphenytoin—Asthenia—Betamethasone—hematologic cancer	1.94e-05	7.18e-05	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.94e-05	7.17e-05	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—hematologic cancer	1.93e-05	7.14e-05	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—hematologic cancer	1.93e-05	7.13e-05	CcSEcCtD
Fosphenytoin—Nausea—Prednisolone—hematologic cancer	1.92e-05	7.12e-05	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—hematologic cancer	1.92e-05	7.11e-05	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—hematologic cancer	1.92e-05	7.11e-05	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—hematologic cancer	1.92e-05	7.1e-05	CcSEcCtD
Fosphenytoin—Pruritus—Betamethasone—hematologic cancer	1.91e-05	7.08e-05	CcSEcCtD
Fosphenytoin—Pruritus—Dexamethasone—hematologic cancer	1.91e-05	7.08e-05	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—hematologic cancer	1.9e-05	7.04e-05	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—hematologic cancer	1.9e-05	7.02e-05	CcSEcCtD
Fosphenytoin—Vomiting—Triamcinolone—hematologic cancer	1.89e-05	7.01e-05	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—hematologic cancer	1.88e-05	6.97e-05	CcSEcCtD
Fosphenytoin—Rash—Triamcinolone—hematologic cancer	1.88e-05	6.95e-05	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—hematologic cancer	1.88e-05	6.95e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Triamcinolone—hematologic cancer	1.88e-05	6.95e-05	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—hematologic cancer	1.88e-05	6.94e-05	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—hematologic cancer	1.88e-05	6.94e-05	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—hematologic cancer	1.87e-05	6.93e-05	CcSEcCtD
Fosphenytoin—Urticaria—Prednisone—hematologic cancer	1.87e-05	6.92e-05	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—hematologic cancer	1.87e-05	6.92e-05	CcSEcCtD
Fosphenytoin—Headache—Triamcinolone—hematologic cancer	1.87e-05	6.91e-05	CcSEcCtD
Fosphenytoin—Body temperature increased—Prednisone—hematologic cancer	1.86e-05	6.89e-05	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—hematologic cancer	1.86e-05	6.87e-05	CcSEcCtD
Fosphenytoin—Diarrhoea—Dexamethasone—hematologic cancer	1.85e-05	6.85e-05	CcSEcCtD
Fosphenytoin—Diarrhoea—Betamethasone—hematologic cancer	1.85e-05	6.85e-05	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—hematologic cancer	1.85e-05	6.83e-05	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—hematologic cancer	1.84e-05	6.81e-05	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—hematologic cancer	1.84e-05	6.8e-05	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—hematologic cancer	1.84e-05	6.79e-05	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—hematologic cancer	1.83e-05	6.77e-05	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—hematologic cancer	1.82e-05	6.74e-05	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—hematologic cancer	1.81e-05	6.7e-05	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—hematologic cancer	1.81e-05	6.69e-05	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—hematologic cancer	1.8e-05	6.67e-05	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—hematologic cancer	1.8e-05	6.67e-05	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—hematologic cancer	1.8e-05	6.65e-05	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.79e-05	6.63e-05	CcSEcCtD
Fosphenytoin—Dizziness—Betamethasone—hematologic cancer	1.79e-05	6.62e-05	CcSEcCtD
Fosphenytoin—Dizziness—Dexamethasone—hematologic cancer	1.79e-05	6.62e-05	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—hematologic cancer	1.78e-05	6.59e-05	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—hematologic cancer	1.78e-05	6.59e-05	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—hematologic cancer	1.78e-05	6.58e-05	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—hematologic cancer	1.78e-05	6.58e-05	CcSEcCtD
Fosphenytoin—Nausea—Triamcinolone—hematologic cancer	1.77e-05	6.55e-05	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—hematologic cancer	1.77e-05	6.54e-05	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—hematologic cancer	1.76e-05	6.5e-05	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—hematologic cancer	1.76e-05	6.5e-05	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—hematologic cancer	1.75e-05	6.49e-05	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—hematologic cancer	1.75e-05	6.47e-05	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—hematologic cancer	1.74e-05	6.43e-05	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—hematologic cancer	1.73e-05	6.41e-05	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—hematologic cancer	1.72e-05	6.37e-05	CcSEcCtD
Fosphenytoin—Vomiting—Dexamethasone—hematologic cancer	1.72e-05	6.36e-05	CcSEcCtD
Fosphenytoin—Vomiting—Betamethasone—hematologic cancer	1.72e-05	6.36e-05	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—hematologic cancer	1.72e-05	6.36e-05	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—hematologic cancer	1.71e-05	6.33e-05	CcSEcCtD
Fosphenytoin—Rash—Dexamethasone—hematologic cancer	1.7e-05	6.31e-05	CcSEcCtD
Fosphenytoin—Rash—Betamethasone—hematologic cancer	1.7e-05	6.31e-05	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.7e-05	6.31e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Dexamethasone—hematologic cancer	1.7e-05	6.3e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Betamethasone—hematologic cancer	1.7e-05	6.3e-05	CcSEcCtD
Fosphenytoin—Headache—Betamethasone—hematologic cancer	1.69e-05	6.27e-05	CcSEcCtD
Fosphenytoin—Headache—Dexamethasone—hematologic cancer	1.69e-05	6.27e-05	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—hematologic cancer	1.69e-05	6.26e-05	CcSEcCtD
Fosphenytoin—Asthenia—Prednisone—hematologic cancer	1.69e-05	6.25e-05	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.68e-05	6.21e-05	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—hematologic cancer	1.68e-05	6.2e-05	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.67e-05	6.17e-05	CcSEcCtD
Fosphenytoin—Pruritus—Prednisone—hematologic cancer	1.67e-05	6.16e-05	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—hematologic cancer	1.67e-05	6.16e-05	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—hematologic cancer	1.66e-05	6.15e-05	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—hematologic cancer	1.65e-05	6.12e-05	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.65e-05	6.1e-05	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—hematologic cancer	1.64e-05	6.08e-05	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—hematologic cancer	1.64e-05	6.06e-05	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—hematologic cancer	1.62e-05	6.01e-05	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—hematologic cancer	1.62e-05	6e-05	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—hematologic cancer	1.62e-05	6e-05	CcSEcCtD
Fosphenytoin—Diarrhoea—Prednisone—hematologic cancer	1.61e-05	5.96e-05	CcSEcCtD
Fosphenytoin—Nausea—Betamethasone—hematologic cancer	1.61e-05	5.94e-05	CcSEcCtD
Fosphenytoin—Nausea—Dexamethasone—hematologic cancer	1.61e-05	5.94e-05	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—hematologic cancer	1.6e-05	5.92e-05	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—hematologic cancer	1.59e-05	5.89e-05	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—hematologic cancer	1.57e-05	5.83e-05	CcSEcCtD
Fosphenytoin—Urticaria—Methotrexate—hematologic cancer	1.56e-05	5.78e-05	CcSEcCtD
Fosphenytoin—Dizziness—Prednisone—hematologic cancer	1.56e-05	5.76e-05	CcSEcCtD
Fosphenytoin—Body temperature increased—Methotrexate—hematologic cancer	1.56e-05	5.76e-05	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.55e-05	5.74e-05	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—hematologic cancer	1.54e-05	5.7e-05	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—hematologic cancer	1.53e-05	5.66e-05	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—hematologic cancer	1.52e-05	5.62e-05	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—hematologic cancer	1.52e-05	5.62e-05	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—hematologic cancer	1.51e-05	5.61e-05	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—hematologic cancer	1.5e-05	5.55e-05	CcSEcCtD
Fosphenytoin—Vomiting—Prednisone—hematologic cancer	1.5e-05	5.54e-05	CcSEcCtD
Fosphenytoin—Rash—Prednisone—hematologic cancer	1.48e-05	5.49e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisone—hematologic cancer	1.48e-05	5.49e-05	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—hematologic cancer	1.48e-05	5.48e-05	CcSEcCtD
Fosphenytoin—Headache—Prednisone—hematologic cancer	1.48e-05	5.46e-05	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—hematologic cancer	1.46e-05	5.41e-05	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—hematologic cancer	1.46e-05	5.39e-05	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—hematologic cancer	1.46e-05	5.39e-05	CcSEcCtD
Fosphenytoin—Asthenia—Methotrexate—hematologic cancer	1.41e-05	5.22e-05	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—hematologic cancer	1.4e-05	5.2e-05	CcSEcCtD
Fosphenytoin—Nausea—Prednisone—hematologic cancer	1.4e-05	5.18e-05	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—hematologic cancer	1.39e-05	5.15e-05	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—hematologic cancer	1.35e-05	5.01e-05	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—hematologic cancer	1.35e-05	4.98e-05	CcSEcCtD
Fosphenytoin—Diarrhoea—Methotrexate—hematologic cancer	1.35e-05	4.98e-05	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—hematologic cancer	1.32e-05	4.89e-05	CcSEcCtD
Fosphenytoin—Pruritus—Epirubicin—hematologic cancer	1.3e-05	4.82e-05	CcSEcCtD
Fosphenytoin—Dizziness—Methotrexate—hematologic cancer	1.3e-05	4.82e-05	CcSEcCtD
Fosphenytoin—Diarrhoea—Epirubicin—hematologic cancer	1.26e-05	4.66e-05	CcSEcCtD
Fosphenytoin—Vomiting—Methotrexate—hematologic cancer	1.25e-05	4.63e-05	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—hematologic cancer	1.24e-05	4.59e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—hematologic cancer	1.24e-05	4.59e-05	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—hematologic cancer	1.23e-05	4.56e-05	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—hematologic cancer	1.22e-05	4.52e-05	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—hematologic cancer	1.22e-05	4.51e-05	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—hematologic cancer	1.21e-05	4.46e-05	CcSEcCtD
Fosphenytoin—Vomiting—Epirubicin—hematologic cancer	1.17e-05	4.33e-05	CcSEcCtD
Fosphenytoin—Nausea—Methotrexate—hematologic cancer	1.17e-05	4.33e-05	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—hematologic cancer	1.17e-05	4.31e-05	CcSEcCtD
Fosphenytoin—Rash—Epirubicin—hematologic cancer	1.16e-05	4.3e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—hematologic cancer	1.16e-05	4.29e-05	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—hematologic cancer	1.15e-05	4.27e-05	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—hematologic cancer	1.13e-05	4.17e-05	CcSEcCtD
Fosphenytoin—Nausea—Epirubicin—hematologic cancer	1.09e-05	4.05e-05	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—hematologic cancer	1.08e-05	4.01e-05	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—hematologic cancer	1.07e-05	3.98e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—hematologic cancer	1.07e-05	3.97e-05	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—hematologic cancer	1.07e-05	3.95e-05	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—hematologic cancer	1.01e-05	3.75e-05	CcSEcCtD
Fosphenytoin—CYP2C9—Metabolism—ACP5—hematologic cancer	7.41e-06	0.000208	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SPHK1—hematologic cancer	7.4e-06	0.000207	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NCOR2—hematologic cancer	7.32e-06	0.000205	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NUP98—hematologic cancer	7.31e-06	0.000205	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PC—hematologic cancer	7.3e-06	0.000205	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NUP98—hematologic cancer	7.27e-06	0.000204	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—UGT1A1—hematologic cancer	7.11e-06	0.000199	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ADCY7—hematologic cancer	7.09e-06	0.000199	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NCOA3—hematologic cancer	7.09e-06	0.000199	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—CREBBP—hematologic cancer	7.06e-06	0.000198	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ADCY7—hematologic cancer	7.05e-06	0.000198	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NCOA3—hematologic cancer	7.05e-06	0.000198	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GBA—hematologic cancer	7.05e-06	0.000198	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.05e-06	0.000198	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NUP214—hematologic cancer	7.04e-06	0.000198	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NUP214—hematologic cancer	7e-06	0.000197	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.97e-06	0.000196	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—IDH1—hematologic cancer	6.97e-06	0.000196	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.93e-06	0.000195	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SLC22A1—hematologic cancer	6.91e-06	0.000194	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CRABP1—hematologic cancer	6.91e-06	0.000194	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ABCG2—hematologic cancer	6.9e-06	0.000194	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—MTR—hematologic cancer	6.9e-06	0.000194	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	6.9e-06	0.000194	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTO1—hematologic cancer	6.89e-06	0.000193	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—TXN—hematologic cancer	6.89e-06	0.000193	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ABCC3—hematologic cancer	6.89e-06	0.000193	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—MTR—hematologic cancer	6.86e-06	0.000193	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ABCG2—hematologic cancer	6.86e-06	0.000193	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ENO2—hematologic cancer	6.77e-06	0.00019	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SPHK1—hematologic cancer	6.74e-06	0.000189	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALOX5—hematologic cancer	6.74e-06	0.000189	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ENO2—hematologic cancer	6.73e-06	0.000189	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CD—hematologic cancer	6.69e-06	0.000188	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTT1—hematologic cancer	6.56e-06	0.000184	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTT1—hematologic cancer	6.53e-06	0.000183	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NUP98—hematologic cancer	6.52e-06	0.000183	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—UGT1A1—hematologic cancer	6.48e-06	0.000182	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.46e-06	0.000181	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MTAP—hematologic cancer	6.45e-06	0.000181	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NQO1—hematologic cancer	6.44e-06	0.000181	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CD44—hematologic cancer	6.44e-06	0.000181	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.43e-06	0.00018	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—SDC1—hematologic cancer	6.42e-06	0.00018	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—SDC1—hematologic cancer	6.38e-06	0.000179	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ADCY7—hematologic cancer	6.33e-06	0.000178	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NCOA3—hematologic cancer	6.33e-06	0.000178	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3R1—hematologic cancer	6.32e-06	0.000177	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SLC22A1—hematologic cancer	6.3e-06	0.000177	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CRABP1—hematologic cancer	6.3e-06	0.000177	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NUP214—hematologic cancer	6.29e-06	0.000176	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.22e-06	0.000175	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—MTR—hematologic cancer	6.16e-06	0.000173	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ABCG2—hematologic cancer	6.16e-06	0.000173	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—JAK2—hematologic cancer	6.14e-06	0.000172	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.14e-06	0.000172	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.13e-06	0.000172	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.11e-06	0.000171	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYCS—hematologic cancer	6.1e-06	0.000171	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.09e-06	0.000171	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	6.06e-06	0.00017	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.05e-06	0.00017	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ENO2—hematologic cancer	6.04e-06	0.00017	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NUP98—hematologic cancer	5.95e-06	0.000167	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTT1—hematologic cancer	5.86e-06	0.000164	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CB—hematologic cancer	5.83e-06	0.000164	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.79e-06	0.000162	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.77e-06	0.000162	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.77e-06	0.000162	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.77e-06	0.000162	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.75e-06	0.000161	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—FHL2—hematologic cancer	5.75e-06	0.000161	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NUP214—hematologic cancer	5.73e-06	0.000161	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SDC1—hematologic cancer	5.73e-06	0.000161	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.67e-06	0.000159	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—AGRN—hematologic cancer	5.64e-06	0.000158	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.64e-06	0.000158	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.62e-06	0.000158	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—MTR—hematologic cancer	5.62e-06	0.000158	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ENO2—hematologic cancer	5.51e-06	0.000155	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.47e-06	0.000153	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NQO1—hematologic cancer	5.46e-06	0.000153	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CD44—hematologic cancer	5.46e-06	0.000153	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NQO1—hematologic cancer	5.42e-06	0.000152	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CD44—hematologic cancer	5.42e-06	0.000152	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.4e-06	0.000152	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTP1—hematologic cancer	5.37e-06	0.000151	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IL2—hematologic cancer	5.36e-06	0.00015	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HMMR—hematologic cancer	5.34e-06	0.00015	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—IDH2—hematologic cancer	5.34e-06	0.00015	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.34e-06	0.00015	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.34e-06	0.00015	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.31e-06	0.000149	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.26e-06	0.000148	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SDC1—hematologic cancer	5.22e-06	0.000147	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.17e-06	0.000145	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYCS—hematologic cancer	5.16e-06	0.000145	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYCS—hematologic cancer	5.13e-06	0.000144	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.13e-06	0.000144	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—HSP90AA1—hematologic cancer	5.1e-06	0.000143	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ABCB1—hematologic cancer	5.09e-06	0.000143	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.02e-06	0.000141	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.99e-06	0.00014	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTM1—hematologic cancer	4.94e-06	0.000139	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NCOR1—hematologic cancer	4.94e-06	0.000139	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.92e-06	0.000138	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CA9—hematologic cancer	4.89e-06	0.000137	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ACP5—hematologic cancer	4.89e-06	0.000137	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NQO1—hematologic cancer	4.87e-06	0.000137	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CD44—hematologic cancer	4.87e-06	0.000137	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.82e-06	0.000135	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—EP300—hematologic cancer	4.81e-06	0.000135	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.77e-06	0.000134	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.71e-06	0.000132	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SRC—hematologic cancer	4.68e-06	0.000131	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.62e-06	0.00013	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYCS—hematologic cancer	4.61e-06	0.000129	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—IDH1—hematologic cancer	4.6e-06	0.000129	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.59e-06	0.000129	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	4.58e-06	0.000128	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VEGFA—hematologic cancer	4.55e-06	0.000128	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.55e-06	0.000128	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—TXN—hematologic cancer	4.54e-06	0.000128	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.54e-06	0.000128	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.54e-06	0.000128	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTP1—hematologic cancer	4.52e-06	0.000127	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—NRAS—hematologic cancer	4.5e-06	0.000126	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.45e-06	0.000125	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CD44—hematologic cancer	4.44e-06	0.000125	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NQO1—hematologic cancer	4.44e-06	0.000125	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.4e-06	0.000124	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.38e-06	0.000123	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—MTHFR—hematologic cancer	4.37e-06	0.000122	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.35e-06	0.000122	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—MAPK3—hematologic cancer	4.31e-06	0.000121	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.31e-06	0.000121	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ABCB1—hematologic cancer	4.28e-06	0.00012	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.27e-06	0.00012	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYCS—hematologic cancer	4.2e-06	0.000118	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.18e-06	0.000117	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.18e-06	0.000117	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TGFB1—hematologic cancer	4.18e-06	0.000117	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.17e-06	0.000117	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NCOR1—hematologic cancer	4.16e-06	0.000117	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTM1—hematologic cancer	4.16e-06	0.000117	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.16e-06	0.000117	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.16e-06	0.000117	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.12e-06	0.000116	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.06e-06	0.000114	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.05e-06	0.000114	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.93e-06	0.00011	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NUP98—hematologic cancer	3.92e-06	0.00011	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—KRAS—hematologic cancer	3.87e-06	0.000109	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.84e-06	0.000108	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.81e-06	0.000107	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.81e-06	0.000107	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NUP214—hematologic cancer	3.78e-06	0.000106	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.76e-06	0.000105	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.73e-06	0.000105	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.73e-06	0.000105	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MTR—hematologic cancer	3.7e-06	0.000104	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.7e-06	0.000104	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.7e-06	0.000104	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.7e-06	0.000104	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—MTHFR—hematologic cancer	3.67e-06	0.000103	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CG—hematologic cancer	3.67e-06	0.000103	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ENO2—hematologic cancer	3.63e-06	0.000102	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.58e-06	0.000101	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CA—hematologic cancer	3.56e-06	9.98e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.52e-06	9.89e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.51e-06	9.84e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SDC1—hematologic cancer	3.44e-06	9.66e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TP53—hematologic cancer	3.44e-06	9.65e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.4e-06	9.55e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.4e-06	9.55e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CREBBP—hematologic cancer	3.4e-06	9.54e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.3e-06	9.25e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—HRAS—hematologic cancer	3.29e-06	9.23e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.26e-06	9.14e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.24e-06	9.09e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CD—hematologic cancer	3.22e-06	9.05e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ALB—hematologic cancer	3.18e-06	8.93e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.1e-06	8.71e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CG—hematologic cancer	3.09e-06	8.66e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3R1—hematologic cancer	3.04e-06	8.54e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.01e-06	8.44e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CD44—hematologic cancer	2.93e-06	8.22e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NQO1—hematologic cancer	2.93e-06	8.22e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.91e-06	8.16e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—AKT1—hematologic cancer	2.91e-06	8.15e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.88e-06	8.08e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CREBBP—hematologic cancer	2.86e-06	8.03e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.81e-06	7.88e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.77e-06	7.78e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYCS—hematologic cancer	2.77e-06	7.77e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.75e-06	7.72e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.73e-06	7.66e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CD—hematologic cancer	2.71e-06	7.61e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALB—hematologic cancer	2.69e-06	7.56e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.65e-06	7.44e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.58e-06	7.23e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.57e-06	7.21e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3R1—hematologic cancer	2.56e-06	7.19e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.53e-06	7.09e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.44e-06	6.85e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.44e-06	6.84e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTEN—hematologic cancer	2.43e-06	6.81e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALB—hematologic cancer	2.41e-06	6.75e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.38e-06	6.68e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CB—hematologic cancer	2.37e-06	6.64e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.34e-06	6.57e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—EP300—hematologic cancer	2.32e-06	6.5e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.31e-06	6.49e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.3e-06	6.45e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.24e-06	6.3e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.24e-06	6.3e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.22e-06	6.23e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALB—hematologic cancer	2.19e-06	6.15e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.12e-06	5.96e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.1e-06	5.89e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTEN—hematologic cancer	2.06e-06	5.77e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTEN—hematologic cancer	2.04e-06	5.74e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.98e-06	5.57e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—EP300—hematologic cancer	1.96e-06	5.5e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—EP300—hematologic cancer	1.95e-06	5.47e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.94e-06	5.43e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTEN—hematologic cancer	1.84e-06	5.15e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—EP300—hematologic cancer	1.75e-06	4.91e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.71e-06	4.81e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTEN—hematologic cancer	1.67e-06	4.69e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.67e-06	4.68e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—EP300—hematologic cancer	1.6e-06	4.48e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.55e-06	4.34e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.47e-06	4.11e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.45e-06	4.07e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALB—hematologic cancer	1.45e-06	4.06e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CA—hematologic cancer	1.44e-06	4.05e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—AKT1—hematologic cancer	1.4e-06	3.93e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.38e-06	3.88e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.29e-06	3.63e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.28e-06	3.58e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—AKT1—hematologic cancer	1.18e-06	3.32e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.18e-06	3.31e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—AKT1—hematologic cancer	1.18e-06	3.31e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTEN—hematologic cancer	1.1e-06	3.1e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—AKT1—hematologic cancer	1.06e-06	2.97e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—EP300—hematologic cancer	1.05e-06	2.95e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—AKT1—hematologic cancer	9.64e-07	2.71e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.78e-07	2.18e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—AKT1—hematologic cancer	6.36e-07	1.78e-05	CbGpPWpGaD
